Croda International PLC
LSE:CRDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (20.1), the stock would be worth GBX3 448.55 (13% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 17.8 | GBX3 051 |
0%
|
| 3-Year Average | 20.1 | GBX3 448.55 |
+13%
|
| 5-Year Average | 21.5 | GBX3 682.61 |
+21%
|
| Industry Average | 0 | GBX8.5 |
-100%
|
| Country Average | 0 | GBX5.02 |
-100%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
GBX4.4B
|
/ |
Jan 2026
£259.6m
|
= |
|
|
GBX4.4B
|
/ |
Dec 2026
£313.2m
|
= |
|
|
GBX4.4B
|
/ |
Dec 2027
£352m
|
= |
|
|
GBX4.4B
|
/ |
Dec 2028
£390.6m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Croda International PLC
LSE:CRDA
|
4.3B GBP | 17.8 | 68.7 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
85.6B USD | 25.3 | 33.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.9T JPY | 18.2 | 26.6 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
77.5B USD | 29.1 | 37.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 7.1 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282.1B CNY | 21.3 | 24.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26.6B CHF | 22.6 | 25.6 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 37.9 | 54.8 | |
| US |
|
Albemarle Corp
NYSE:ALB
|
23.3B USD | 299.7 | -34.4 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 45.2 | 61.2 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
25.7B USD | 13.9 | 16.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0.1 |
| Max | 1 015 |
Other Multiples
Croda International PLC
Glance View
In the heart of Britain, Croda International PLC has crafted a narrative of innovation and sustainability within the specialty chemicals industry. Founded in 1925, the company initially rode the soap manufacturing wave but has since transformed into a global powerhouse by focusing on niche markets where it can exert its expertise. Croda has adeptly positioned itself in three key sectors: Personal Care, Life Sciences, and Performance Technologies. Its business model thrives on leveraging scientific research to create high-performance ingredients designed to elevate an array of consumer and industrial applications. Croda’s commitment to leveraging chemistry and natural resources, often derived from renewable sources, sets it apart in a market that increasingly values sustainability. Croda’s financial success emanates from its ability to capture value through innovation and product differentiation, a strategy that has culminated in a diverse portfolio that meets complex customer needs. In Personal Care, Croda's ingredients fuel the beauty and cosmetic industries with components that promise efficacy and safety, often carrying sustainability credentials. The Life Sciences division delves deeper into agricultural and pharmaceutical solutions, providing crop-enhancing chemicals and vital drug delivery systems, which are crucial for advancing food production and healthcare. Meanwhile, Performance Technologies focuses on delivering materials that enhance the reliability and efficiency of industrial products such as lubricants and coatings. This broad yet specialized approach allows Croda to maintain robust growth by integrating cutting-edge science with a keen awareness of market demands, ensuring its products remain indispensable across various sectors around the globe.